ENZYCHEM LIFESCIENCES CORPORATION
Develops small molecule therapeutics for cancer, inflammation, and respiratory diseases.
183490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7183490002
- LEI:
- Country:
- South Korea
- Address:
- 충청북도 제천시 바이오밸리로 59, 제천시
- Website:
- https://www.enzychem.com/
- Sector:
- Manufacturing
Description
Enzychem Lifesciences Corporation is a biopharmaceutical company that develops novel small molecule therapeutics. The company's research targets fundamental pathways in inflammation to address significant unmet medical needs for patients with cancer, inflammatory diseases, and severe respiratory conditions. Its leading drug candidate, EC-18 (Mosedipimod), is a first-in-class oral small molecule derived from Sika deer antler. The clinical pipeline for EC-18 includes indications such as chemoradiation-induced oral mucositis (CRIOM), chemotherapy-induced neutropenia (CIN), acute radiation syndrome (ARS), and non-alcoholic steatohepatitis (NASH). The company also develops and manufactures Active Pharmaceutical Ingredients (APIs).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-12 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | HTML • 22.1 KB | ||
| 2021-03-08 00:00 |
증권발행결과(자율공시)(제3자배정 유상증자-전환우선주)
|
Korean | HTML • 5.6 KB | ||
| 2021-03-08 00:00 |
전환가액의조정(제2회차)
|
Korean | HTML • 10.4 KB | ||
| 2021-03-03 00:00 |
증권발행결과(자율공시)(제3자배정 유상증자-전환우선주)
|
Korean | HTML • 5.6 KB | ||
| 2021-03-03 00:00 |
전환가액의조정(제2회차)
|
Korean | HTML • 9.9 KB | ||
| 2021-02-26 00:00 |
주요사항보고서(유상증자결정)
|
Korean | HTML • 58.7 KB | ||
| 2021-02-23 00:00 |
주요사항보고서(유상증자결정)
|
Korean | HTML • 92.3 KB | ||
| 2021-02-09 00:00 |
전환가액의조정(제2회차)
|
Korean | HTML • 10.2 KB | ||
| 2020-12-16 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | HTML • 4.1 KB | ||
| 2020-12-09 00:00 |
기업설명회(IR)개최
|
Korean | HTML • 7.7 KB | ||
| 2020-11-16 00:00 |
분기보고서 (2020.09)
|
Korean | HTML • 1.9 MB | ||
| 2020-11-06 00:00 |
증권발행결과(자율공시)(제2회차 CB)
|
Korean | HTML • 6.0 KB | ||
| 2020-11-04 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | HTML • 66.0 KB | ||
| 2020-10-05 00:00 |
기업설명회(IR)개최
|
Korean | HTML • 8.4 KB | ||
| 2020-09-25 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | HTML • 23.5 KB |
Automate Your Workflow. Get a real-time feed of all ENZYCHEM LIFESCIENCES CORPORATION filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ENZYCHEM LIFESCIENCES CORPORATION
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ENZYCHEM LIFESCIENCES CORPORATION via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
